Ohlbe ★★★ France, 2020-04-28 23:01 (310 d 13:10 ago) Posting: # 21358 Views: 2,509 |
|
Dear all, The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence. — Regards Ohlbe |